New Haven Pharmaceuticals
North Haven, US · Delaware corporation
Founders & leadership
PF
Patrick FourteauExecutive
NM
Nancy MotolaExecutive
HH
Harry H. Penner, Jr.Named on SEC filing
Board
CE
Christopher EcklundBoard director
TS
Theodore StanleyBoard director
WS
William SessaBoard director
DW
Daniel WagnerBoard director
LD
Larry DillahaBoard director
Reported raises · per SEC filings
Form D private placements$12.4M disclosed across 2 rounds · 2014–2016
▶$602.2KraisedAug 2016 · 3 investors · PharmaceuticalsRule 506(b)
▶$602.2KraisedAug 2016 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Harry H. Penner, Jr.Executive Officer, Director
- Christopher EcklundDirector
- Theodore StanleyDirector
- William SessaDirector
- Daniel WagnerDirector
- Larry DillahaDirector
- Patrick FourteauExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $602.2K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.8MraisedOct 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$11.8MraisedOct 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William SessaDirector
- Larry DillahaDirector
- Harry Penner, Jr.Executive Officer, Director
- Patrick FourteauExecutive Officer, Director
- Daniel WagnerDirector
- Nancy MotolaExecutive Officer
- Offering amount
- $21.8M
- Amount sold
- $11.8M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has New Haven Pharmaceuticals raised?
- New Haven Pharmaceuticals has disclosed $12.4M raised across 2 rounds.
- Where is New Haven Pharmaceuticals headquartered?
- New Haven Pharmaceuticals is headquartered in North Haven, US.